Nikola A. Bowden

3.2k total citations · 1 hit paper
67 papers, 2.3k citations indexed

About

Nikola A. Bowden is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Nikola A. Bowden has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Immunology. Recurrent topics in Nikola A. Bowden's work include DNA Repair Mechanisms (17 papers), Ovarian cancer diagnosis and treatment (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Nikola A. Bowden is often cited by papers focused on DNA Repair Mechanisms (17 papers), Ovarian cancer diagnosis and treatment (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Nikola A. Bowden collaborates with scholars based in Australia, United Kingdom and Sweden. Nikola A. Bowden's co-authors include Michelle W. Wong‐Brown, Rodney J. Scott, Paul A. Tooney, Timothy Budden, André van der Westhuizen, Natalie J. Beveridge, Nham Tran, Murray J. Cairns, Erin Gardiner and Irina Dedova and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Nikola A. Bowden

65 papers receiving 2.3k citations

Hit Papers

BCL-2 family isoforms in apoptosis and cancer 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikola A. Bowden Australia 23 1.4k 538 456 358 279 67 2.3k
Sumedha Gunewardena United States 32 1.7k 1.2× 570 1.1× 500 1.1× 323 0.9× 274 1.0× 105 3.0k
Emanuela Grassilli Italy 29 1.9k 1.4× 418 0.8× 797 1.7× 353 1.0× 157 0.6× 58 2.9k
Gigliola Sica Italy 26 866 0.6× 403 0.7× 479 1.1× 281 0.8× 197 0.7× 71 2.3k
Andrea Nist Germany 27 1.6k 1.2× 432 0.8× 491 1.1× 551 1.5× 177 0.6× 81 2.4k
Lijun Tan China 24 1.2k 0.9× 331 0.6× 347 0.8× 176 0.5× 335 1.2× 87 2.3k
Yanan Yang China 29 1.8k 1.4× 736 1.4× 668 1.5× 267 0.7× 170 0.6× 100 2.8k
Stefania Gelmini Italy 35 1.3k 1.0× 716 1.3× 528 1.2× 282 0.8× 214 0.8× 79 2.9k
Hui Hua China 24 1.8k 1.3× 501 0.9× 562 1.2× 388 1.1× 177 0.6× 63 3.0k
Huijian Wu China 27 1.5k 1.1× 448 0.8× 425 0.9× 151 0.4× 296 1.1× 66 2.4k

Countries citing papers authored by Nikola A. Bowden

Since Specialization
Citations

This map shows the geographic impact of Nikola A. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikola A. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikola A. Bowden more than expected).

Fields of papers citing papers by Nikola A. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikola A. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikola A. Bowden. The network helps show where Nikola A. Bowden may publish in the future.

Co-authorship network of co-authors of Nikola A. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Nikola A. Bowden. A scholar is included among the top collaborators of Nikola A. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikola A. Bowden. Nikola A. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bond, Danielle R., B. M. R. Harvey, Luiza Steffens Reinhardt, et al.. (2025). Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal. Leukemia. 39(9). 2275–2280.
3.
Lumbers, Eugenie R., Nikola A. Bowden, Jennifer Martin, et al.. (2024). Upregulation of the Renin–Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells. 13(7). 634–634. 3 indexed citations
4.
Ou, Tong, Hao‐Cheng Yang, Xiaoqiang Zhu, et al.. (2024). ERCC2 mutations alter the genomic distribution pattern of somatic mutations and are independently prognostic in bladder cancer. Cell Genomics. 4(8). 100627–100627. 2 indexed citations
5.
Jaaback, Kenneth, Michelle W. Wong‐Brown, Partha Dutta, et al.. (2024). Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells. 13(8). 717–717. 6 indexed citations
6.
Faulkner, Sam, et al.. (2023). Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma. Cancers. 15(15). 3922–3922. 4 indexed citations
7.
Westhuizen, André van der, Megan Lyle, Moira C. Graves, et al.. (2022). Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge. Cancer Research Communications. 2(8). 814–826. 3 indexed citations
8.
Navani, Vishal, et al.. (2021). Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers. Pharmacology Research & Perspectives. 9(4). e00808–e00808. 7 indexed citations
10.
Navani, Vishal, Moira C. Graves, Nikola A. Bowden, & André van der Westhuizen. (2020). Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response. British Journal of Clinical Pharmacology. 86(9). 1736–1752. 13 indexed citations
11.
Graves, Moira C., et al.. (2019). Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles. Frontiers in Medicine. 6. 113–113. 17 indexed citations
12.
Bowden, Nikola A., et al.. (2018). Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment. Endocrine Related Cancer. 25(5). R303–R318. 149 indexed citations
13.
Hardy, Margaret C., Adrian Carter, & Nikola A. Bowden. (2016). What do postdocs need to succeed? A survey of current standing and future directions for Australian researchers. Palgrave Communications. 2(1). 15 indexed citations
14.
Day, Tania, Nikola A. Bowden, Kenneth Jaaback, Geoff Otton, & James Scurry. (2016). Distinguishing Erosive Lichen Planus From Differentiated Vulvar Intraepithelial Neoplasia. Journal of Lower Genital Tract Disease. 20(2). 174–179. 13 indexed citations
15.
Murray, Heather C., Vicki E. Maltby, Doug W. Smith, & Nikola A. Bowden. (2015). Nucleotide excision repair deficiency in melanoma in response to UVA. Experimental Hematology and Oncology. 5(1). 6–6. 20 indexed citations
16.
Bowden, Nikola A.. (2014). Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?. Cancer Letters. 346(2). 163–171. 117 indexed citations
17.
Symonds, Ian, Jane M. Finnie, Nikola A. Bowden, et al.. (2013). Progesterone Activates Multiple Innate Immune Pathways in C hlamydia trachomatis ‐Infected Endocervical Cells. American Journal of Reproductive Immunology. 71(2). 165–177. 25 indexed citations
18.
Bowden, Nikola A., Katie A. Ashton, Kelly A. Avery‐Kiejda, et al.. (2010). Nucleotide Excision Repair Gene Expression after Cisplatin Treatment in Melanoma. Cancer Research. 70(20). 7918–7926. 24 indexed citations
19.
Baines, Katherine J., Jodie L. Simpson, Nikola A. Bowden, Rodney J. Scott, & Peter G. Gibson. (2009). Differential gene expression and cytokine production from neutrophils in asthma phenotypes. European Respiratory Journal. 35(3). 522–531. 78 indexed citations
20.
Bowden, Nikola A., Rodney J. Scott, & Paul A. Tooney. (2006). Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia. Schizophrenia Research. 89(1-3). 165–168. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026